Market

Director's Report

You can view full text of the latest Director's Report for the company.

DIRECTORS' REPORT

Simran Farms Ltd.

GO
Market Cap. ( ₹ in Cr. ) 61.05 P/BV 1.46 Book Value ( ₹ ) 110.15
52 Week High/Low ( ₹ ) 209/142 FV/ML 10/1 P/E(X) 10.38
Book Closure 12/09/2024 EPS ( ₹ ) 15.50 Div Yield (%) 0.00
Year End :2025-03 

On behalf of the Board of Directors (the “Board”) of the Company, it gives us an immense pleasure to present the
38th Board’s Report, along with the Standalone and Consolidated Audited Financial Statements of Company for
the financial year ended March 31,2025.

1. STATE OF AFFAIRS AND FINANCIAL PERFORMANCE:

1.1 FINANCIAL HIGHLIGHTS & SUMMARY OF STANDALONE & CONSOLIDATED FINANCIAL
STATEMENTS

The Standalone and Consolidated Financial Statements of the Company for the financial year ended
March 31, 2025, have been prepared in accordance with the Indian Accounting Standards (Ind AS) as
notified by the Ministry of Corporate Affairs and as amended from time to time.

The Company’s performance highlights and summarized financial results, during the financial year 2024¬
25 as compared to the previous financial year ofthe Company are given below: ,, , ,, ..

(Amount In Lakhs Except EPS

Particulars

Standalone

Consolidated

Year Ended

Year Ended

March 31,

March 31,

March 31,

March 31,

2025

2024

2025

2024

Total Income

83624.22

48868.75

83624.22

48868.75

Total Expenditure

82828.34

48818.04

82814.50

48805.74

Profit/Loss before exceptional &
extra-ordinary items and tax

795.88

50.71

809.72

63.01

Exceptional Items

0.00

0.00

0.00

0.00

Profit/Loss before tax

795.88

50.71

809.72

63.01

Tax Expenses:
a) Less: Current Tax

224.83

11.38

229.75

15.93

b) Less: Tax adjustment relating to

0.15

7.44

0.15

7.44

previ ous years

c) (Add)/Less: Deferred tax (assets)
/Liabilities

(8.60)

0.77

(9.80)

(0.30)

Profit/Loss after tax before
comprehensive income

579.50

31.12

589.62

39.94

Other Comprehensive Income

(19.59)

(13.16)

(19.59)

(13.16)

Total comprehensive income for
the year

559.91

17.96

570.02

26.78

Paid up Equity Share Capital

379.17

379.17

379.17

379.17

Earnings per share (INR 10/- each)
Basic (in INR)

Diluted (in INR)

15.28

0.82

15.55

1.01

14.20

0.82

14.45

1.01

1.2 OPERATIONAL AND STATE OF AFFAIRS OF THE COMPANY

The Company is engaged in the business of integrated poultry and poultry farming. The company is mainly
focused on integration and consolidation of poultry activities and has arranged large manufacturing set-up

for production of poultry feed for self-consumption. Company is an integrated company with expertise
across the poultry value chain and its management has vast experience in the poultry industry.

The Company’s performance during Financial Year 2024-25 on a standalone and consolidated basis were
as follows -

A. On Standalone basis

During the year ended March 31,2025, the Company has achieved total income of INR 83624.22 Lakhs as
against INR 48868.75 Lakhs in the previous year. Further, the Company earned a net profit (Before
Comprehensive Income) of INR 579.50 Lakhs as compared to INR 31.12 Lakhs in last year. The significant
increase in profits can be attributed primarily to the heightened demand for poultry products, improved
price realization for broilers, and enhanced operational efficiency. Furthermore, a reduced incidence of
disease, better feed conversion ratios, and effective cost management initiatives also played a vital role in
boosting productivity and margins, resulting in a robust overall performance for the year. This growth
reflects not only higher sales and better price realization but also improved operational performance
through efficient farm management, enhanced productivity, and better cost control. The consistent efforts
of the management in strengthening processes, optimizing resources, and focusing on quality and
efficiency played a key role in achieving these results.

B. On Consolidated basis

During the year under review, total income on consolidated basis was same as Standalone basis i.e. INR
83624.22 Lakhs in comparison to INR 48868.75 Lakhs in previous year. Further, the Company’s earned a
profit (Before Comprehensive Income) of INR 589.62 Lakhs against profit of INR 39.94 Lakhs in previous
year.

2. ANNUAL RETURN

Pursuant to Section 134(3)(a) of the Companies Act, 2013, the requirement to place copy of Annual Return
for the financial year 2024-25 prepared in accordance with Section 92(3) of the Companies Act, 2013 is
made available on the website of your Company and can be assessed using the web link i.e.
http://simranfarms.com/pdf/notices/form_mgt_7_simran_202425.pdf

3. SHARE CAPITAL

The Paid-up Equity Share Capital as on 31st March 2025 stood at INR 379.17 Lakhs. During the year
under review, there was no change in capital structure of the Company. Further, the company has not
issued any shares with differential voting rights nor granted any stock option or sweat equity shares.

4. PREFERENTIAL ISSUE OF CONVERTIBLE SHARE WARRANTS

Pursuant to the approval of the Board at its meeting held on 14th August, 2024 and approval of the
members of the Company at their 37th Annual General Meeting ('AGM') held on 12th September, 2024,
upon receipt of 25% of the issue price per warrant (i.e. INR 38.75/- per warrant) as upfront payment
("Warrant Subscription Price"), the Company, on 26th October, 2024 has allotted 10,18,300 (Ten Lakhs
Eighteen Thousand Three Hundred) convertible share warrants, on preferential basis to the member of
Promoter Group of the Company and certain identified non-promoter persons/other entity, at a price of INR
155/- each ("Warrant Issue Price").

Each warrant, so allotted, is convertible into one fully paid-up equity share of the Company having face
value of INR 10/- (Rupees Ten only) each in accordance with the provisions of Securities and Exchange
Board of India (Issue of Capital and Disclosure Requirements) Regulations, 2018, on payment of the
balance consideration of INR116.25/- per warrant ("Warrant Exercise Price"), being 75% of the issue price
per warrant from the Allottees pursuant to exercise of conversion option against each such warrant, within

18 months from the date of allotment of warrants.

The details of utilization of funds are given hereunder:

Original Object

Modified
Object,
if any

Original

Alloca¬

tion

Modified
allocation,
if any

Funds

Utilized

Amount of
Deviation/
Variation for
the quarter
according to
applicable
object

Remarks if any

Expansion of parent farms
and to Meet requirement of
working capital for purchase
of raw material, parent birds
and to develop the broiler
farming in other states

Not

applica

ble

394.59

Nil

394.59

Nil

As on 31st March,
2025, the fund has
been fully utilized
for the objects or
purposes for which
the funds have
been raised.

Further, as on 31st March 2025, except Mr. Kawaljeet Singh Bhatia and Mr. Gurmeet Singh Bhatia, Whole
Time Directors of the Company none of the Directors of the company hold instruments convertible into
equity shares of the Company. Details of convertible warrants held by directors are as under:

Name of the Director No. of convertible warrant

Mr. Kawaljeet Singh Bhatia 77,132

Mr. Gurmeet Singh Bhatia 60,183

5. NUMBER OF BOARD MEETINGS, COMMITTEE MEETINGS AND GENERAL MEETING:

The Board met 7 (Seven) times during the FY 2024-25, the details of which are given in the Corporate
Governance Report forming part of the Annual Report. The maximum interval between any two Board
meetings did not exceed 120 days, as prescribed in the Companies Act, 2013 and the SEBI (Listing
Obligations and Disclosure Requirements) Regulations, 2015 ("SEBI Listing Regulations").

Information on the meeting of Audit Committee, Nomination and Remuneration Committee (“NRC”),
Stakeholders Relationship Committee (“SRC”) and Finance Committee held during the year are given in
the Corporate Governance Report.

Further, 37th Annual General Meeting of the Company for financial year 2023-24 was held on 12th
September, 2024, and no Extra Ordinary General Meeting of the Company was held during the financial
year 2024-25

Postal Ballot:-

Details of resolutions passed through postal ballot mechanism during the financial year 2024-25 are
provided in the section 'General Body Meetings' of the Corporate Governance Report.

6. DIVIDEND

Due to inadequate profit, your Directors have not recommended any dividend for the year under review.

7. AMOUNT TRANSFERRED TO RESERVES

The Board of Directors has decided to retain the entire amount of profit for F.Y 2024-25 appearing in the

Statement of Profit and Loss. Accordingly, your company has not transferred any amount to General
Reserves for the year ended 31st March, 2025.

8. DEPOSITS

During the year under review, the Company has not accepted any deposits from the public within the
meaning of Section 73 of the Companies Act, 2013 read with Companies (Acceptance of Deposits) Rules,
2014 as amended from time to time.

THE DETAILS OF DEPOSITS WHICH ARE NOT IN COMPLIANCE WITH THE REQUIREMENTS OF
CHAPTER V OF THE ACT

Not applicable since Company has not accepted any deposits, therefore the question does not arise
regarding non-compliance with the requirements of Chapter V of the Act.

DISCLOSURE OF UNSECURED LOAN FROM DIRECTORS

Pursuant to Section 2(31) of the Companies Act, 2013 read with Rule 2(1)(c)(viii) of Companies
(Acceptance of Deposits) Rules, 2014, (including any statutory modification or re-enactment thereof for
the time being in force), during the year, the Company has received unsecured loan of INR 175.00 Lakhs
from Mr. Gurmeet Singh Bhatia, Whole Time Director of the Company.

9. DETAILS OF SUBSIDIARY, JOINT VENTURE OR ASSOCIATE COMPANY

As on March 31, 2025, your Company has only one subsidiary company in the name of PUREGENE
BIOTECH LIMITED (CIN: U01222MP1999PLC013303).

During the year, Board of Directors had reviewed the affairs of the Subsidiary Company. The Consolidated
Financial Statement of your Company is prepared in accordance with Section 129(3) of the Companies
Act, 2013 and forms part of this Annual Report.

A separate statement containing salient features of the financial statement of the subsidiary company in
accordance with Section 129(3) of the Companies Act, 2013 and rules made there under in the prescribed
Form AOC-1 is annexed to this Report as
ANNEXURE-A and hence is not repeated here for sake of
brevity. Also, there has been no material change in the nature of the business of the subsidiary company.

In accordance with fourth proviso to Section 136(1) of the Companies Act, 2013, the Annual Report of your
Company containing inter alia the Audited Standalone and Consolidated Financial Statements of the
Company for the financial year ended 31st March, 2025, along with relevant documents, has been placed
on the website of the Company at www.simranfarms.com. Further, Audited Financial Statements together
with related information of the subsidiary company have also been placed on the website of the Company
at www.simranfarms.com.

In terms of Section 136 of the Companies Act, 2013 (‘the Act’), financial statement of the subsidiary
company is not required to be sent to the members of the Company. The Company shall provide a copy of
the annual accounts of its subsidiary company to the members of the Company on their request. The
annual accounts of its subsidiary company will also be kept open for inspection at the registered office of
the Company during business hours.

Further, the Company does not have any joint venture or associate company during the year or at any time
after the closure of the year ended till the date of the report. Further there are no companies that have
become or ceased to be the subsidiary, associate or joint venture of the Company during the financial year
2024-25.

Pursuant to the requirement of Regulation 34(3) read with Schedule V of the SEBI Listing Regulations, the
details of investments made in the subsidiary have been furnished in Notes forming part of the Accounts.

Further Company has not given any loans/advances to the subsidiary of the Company.

MATERIAL SUBSIDIARY:

During the year under review, Company does not have any material subsidiary company.

10. CONSOLIDATED FINANCIAL STATEMENTS

The consolidated financial statements of the Company for the year ended 31st March 2025, have been
prepared in accordance with the Indian Accounting Standards (IND AS) 110 - "Consolidated Financial
Statements" as notified by Ministry of Corporate Affairs and as per the general instructions for preparation
of consolidated financial statements given in Schedule III and other applicable provisions of the Act, and in
compliance with the SEBI Listing Regulations.

The Audited Consolidated Financial Statements along with the Auditors' Report thereon forms part of this
Annual Report.

11. DETAILS OF BOARD OF DIRECTORS AND KEY MANAGERIAL PERSONNEL

The Company has a professional Board with an optimum combination of executive and non-executive
directors who bring to the table the right mix of knowledge, skills and expertise. The Board provides
strategic guidance and direction to the Company in achieving its business objectives and protecting the
interest of stakeholders. The composition of the Board of Directors of the Company is in accordance with
the provisions of Section 149 of the Companies Act, 2013 and Regulation 17 of the SEBI Listing
Regulations.

i. Directors liable to retire by rotation seeking re-appointment

In accordance with the provisions of Section 152 of the Companies Act, 2013 and the Company’s
Articles of Association, Mr. Kawaljeet Singh Bhatia (DIN: 00401827) retires by rotation at the
forthcoming Annual General Meeting and being eligible offers himself for re-appointment. The Board
recommends his re-appointment for the consideration of the Members of the Company at the
ensuing Annual General Meeting.

ii. Change in Directors

During the financial year 2024-25, following changes were made in the Composition of Board of
Directors of the Company: -

(i) The Members of the Company, through the Postal Ballot mechanism conducted on 25th June,
2024, approved and confirmed the appointment of
Mr. Satinder Pal Singh Bhatia (DIN:
10549648) as a Non-Executive Independent Director of the Company, for a term commencing
from 29th March, 2024 and ending on 28th March, 2029 (both days inclusive).

(ii) On the recommendation of Nomination and Remuneration Committee, Mrs. Sherry Mac (DIN:
10736916) was appointed as an Additional Director under the category of Non-Executive
Independent Woman Director by the Board of Directors at its Meeting held on 8th August, 2024
for a term of 5 (five) consecutive years commencing from 8th August, 2024 to 7th August, 2029
subject to the approval of the Members at the 37th Annual General Meeting. Later, Members in
their 37th Annual General Meeting confirmed the appointment of Mrs. Sherry Mac (DIN:
10736916) as an Independent Non-Executive Woman Director of the Company for a term of 5
(five) consecutive years commencing from 8th August, 2024 to 7th August, 2029.

(iii) Second and final term of Mrs. Jasmeet Kaur Bhatia (DIN: 06949992) had been completed from
the close of business hours on 13th August, 2024, consequently she ceased/retired from
Directorship of the Company. Your Board places on record its deep appreciation of the valuable

contribution made by her during her tenure as an Independent Director of the Company.

Further, during the current financial year 2025-26, the Board of Directors in their Meeting held on 13th
August, 2025, considered the resignation of Mr. Kawaljeet Singh Bhatia (DIN: 00401827) from the position
of Whole-time Director of the Company with effect from the close of business hours on 13th August, 2025,
due to the desire to hold an executive position in another company in the future. However, he will continue
as Non-Executive Non-Independent Promoter Director of company liable to retire by rotation.

iii. Key Managerial Personnel

As on 31st March, 2025 the following have been designated as the Key Managerial Personnel of
the Company pursuant to Sections 2(51) and 203 of the Companies Act, 2013 read with the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 as amended
from time to time:

1. Mr. Harender Singh Bhatia, (DIN: 00509426) Managing Director

2. Mr. Kawaljeet Singh Bhatia, (DIN: 00401827) Whole Time Director (Ceased w.e.f. the close of
business hours on 13th August, 2025)

3. Mr. Gurmeet Singh Bhatia, (DIN: 00401697) Whole Time Director

4. Mr. Mahesh Patidar, Chief Financial officer

5. CS Tanu Parmar, Company Secretary and Compliance officer

iv. Change in the Key Managerial Personnel

During the Financial Year 2024-25, on the recommendation of Nomination and Remuneration
Committee, the Board of Directors in their Meeting held on 14th August, 2024 considered re¬
appointment of Mr. Harender Singh Bhatia (DIN: 00509426) as a Managing Director and Mr.
Kawaljeet Singh Bhatia (DIN: 00401827) as a Whole-time Director of the Company for further
period of three years w.e.f 14th August, 2024 to 13th August, 2027 subject to the approval of
members in 37th Annual General Meeting. Later, Members in their 37th Annual General Meeting
confirmed the re-appointment of Mr. Harender Singh Bhatia (DIN: 00509426) as a Managing
Director and Mr. Kawaljeet Singh Bhatia (DIN: 00401827) as a Whole-time Director of the Company
for a further period of 3 (three) years w.e.f. 14th August, 2024 to 13th August, 2027.

v. Disqualifications of Directors:

During the year under review, declarations were received from the Directors of the Company
pursuant to Section 164 of the Companies Act, 2013. The Board appraised the same and found that
none of the director is disqualified for holding office as director.

12. DECLARATION BY INDEPENDENT DIRECTOR

The Company has received declaration of independence from all the Independent Directors, as required
under Section 149(7) of the Companies Act, 2013, confirming that they meet the criteria of independence
as provided in Section 149(6) of the Companies Act, 2013 and Regulation 16(1)(b) of SEBI Listing
Regulations as amended from time to time.

Further in terms of Regulation 25(8) of the SEBI Listing Regulations, the Independent Directors have
confirmed that they are not aware of any circumstance or situation which exists or may be reasonably
anticipated that could impair or impact their ability to discharge their duties with an objective independent
judgment and without any external influence and that they are independent of the Management. The
Board of Directors of the Company have taken on record the declaration and confirmation submitted by the
Independent Directors after undertaking due assessment of the veracity of the same.

The Board is of the opinion that the Independent Directors of the Company hold highest standards of
integrity and possess requisite expertise and experience required to fulfill their duties as Independent
Directors.

In terms of Section 150 of the Companies Act, 2013 read with Rule 6 of the Companies (Appointment and
Qualification of Directors) Rules, 2014 as amended up to the date, Independent Directors of the Company
have confirmed that they have registered themselves with the databank maintained by The Indian Institute
of Corporate Affairs, Manesar (“IICA”). The Independent Directors are also required to undertake online
proficiency self-assessment test conducted by the IICA within a period of 2 (two) years from the date of
inclusion of their names in the data bank, unless they meet the criteria specified for exemption.

13. DIRECTORS’ RESPONSIBILITY STATEMENT

Pursuant to Section 134(5) of the Companies Act, 2013, the Board of Directors of your Company, to the
best of their knowledge, belief, ability and explanation obtained by them, confirm that:

a) in the preparation of the annual accounts, the applicable accounting standards had been followed
along with proper explanation relating to material departures, if any;

b) the Directors had selected such accounting policies and applied them consistently and made
judgments and estimates that are reasonable and prudent so as to give a true and fair view of the
state of affairs of the Company at the end of the financial year and of the profit of the Company for
that year;

c) The Directors had taken proper and sufficient care for the maintenance of adequate accounting
records in accordance with the provisions of this Act for safeguarding the assets of the Company
and for preventing and detecting fraud and other irregularities;

d) the Directors had prepared the annual accounts on a going concern basis;

e) the Directors had laid down internal financial controls to be followed by the Company and that such
internal financial controls are adequate and operating effectively;

f) the Directors had devised proper systems to ensure compliance with the provisions of all applicable
laws and that such systems were adequate and operating effectively.

Based on the framework and testing of internal financial controls and compliance systems established and
maintained by the Company, work performed by the internal, statutory, and secretarial auditors and
external agencies, including audit of internal financial controls over financial reporting by the Statutory
Auditors and the reviews performed by Management and the relevant Board Committees, including the
Audit Committee, the Board is of the opinion that the Company's internal financial controls were adequate
and effective during the financial year 2024-25.

14. FAMILIARIZATION PROGRAMMES IMPARTED TO INDEPENDENT DIRECTORS

Your Company has familiarized the Independent Directors, with regard to their roles, rights,
responsibilities, nature of the industry in which your Company operates, the business model of your
Company etc. The Familiarization Programme was imparted to the Independent Directors during the
meetings of the Board of Directors.

The Familiarization Programme for Independent Directors is uploaded on the website of your
Company, and is accessible at:

http://www.simranfarms.com/pdf/policy/familirization_programme_training_imparted_id_202425.pdf

15. MEETING OF INDEPENDENT DIRECTORS

The Independent Directors met once during the year under review. The Meeting was conducted on 23rd

May, 2024 in an informal manner without the presence of the Managing Director, the Whole Time Director,
the Non-Executive Non-Independent Directors and the Chief Financial Officer of the Company.

16. COMMITTEES OF THE BOARD OF DIRECTORS

The Board is assisted by several committees, whose delegated authority enhances role clarity and the
effective execution of responsibilities throughout our business. These committees are tasked with
governance issues and provide periodic reports to the Board on their activities. Each committee evaluates
its effectiveness by reviewing its activities against approved terms of reference in alignment with
delegated powers and authority.

The details of Committees of the Board are given below:

(i) Audit Committee

(ii) Nomination and Remuneration Committee

(iii) Stakeholders Relationship Committee

(iv) Finance Committee

The details with respect to the composition, powers, roles, terms of reference, meetings held and
attendance of the Directors at such Meetings of the relevant Committees are given in detail in the Report
on Corporate Governance of the Company which forms part of this Annual Report.

17. STATEMENT INDICATING THE MANNER IN WHICH FORMAL ANNUAL EVALUATION HAS BEEN
MADE BY THE BOARD OF ITS OWN PERFORMANCE, ITS DIRECTORS AND THAT OF ITS
COMMITTEES

Pursuant to the provisions of Section 134(3)(p) of the Companies Act, 2013 and the SEBI Listing
Regulations, the performance evaluation of all the Directors, Committees, Chairman of the Board and the
Board as a whole was conducted based on the criteria and framework adopted by the Board which
includes assessing the quality, quantity and timelines of flow of information between the Company,
Management and the Board, as it is necessary for the Board to effectively and reasonably perform their
duties.

The performance of the Board was evaluated by the Board after seeking inputs from all the directors on the
basis of the criteria such as the board composition and structure, effectiveness of board processes,
information and functioning, etc.

The performance of the Committees was evaluated by the Board after seeking inputs from the committee
members on the basis of the criteria such as the composition of committees, effectiveness of committee
meetings, etc. The Board and the Nomination and Remuneration Committee reviewed the performance of
the individual directors on the basis of the criteria such as the contribution of the individual director to the
board and committee meetings like preparedness on the issues to be discussed, meaningful and
constructive contribution and inputs in meetings, etc. In addition, the Chairman was also evaluated on the
key aspects of his role. The Directors were satisfied with the evaluation results, which reflected the overall
engagement of the Individual Directors, the Board as a whole and its Committees with the Company.

The Independent Directors has also expressed their satisfaction with overall functioning and
implementations of their suggestions.

Performance Evaluation Criteria for Independent Directors:

The performance evaluation criteria for Independent Directors are determined by the Nomination and
Remuneration Committee. An indicative list of factors that may be evaluated include participation and
contribution by a director, commitment, effective deployment of knowledge and expertise, effective

management of relationship with stakeholders, integrity and maintenance of confidentiality and
independence of behavior and judgments.

Statement with regard to integrity, expertise and experience of the Independent Director appointed
during the year.

During the review period, Mrs. Sherry Mac (DIN: 10736916) was appointed as an Independent Director of
the Company. The Nomination and Remuneration Committee of the Board, at the time of her appointment,
considered that she is a graduate with a Bachelor of Commerce degree from The Bhopal School of Social
Sciences. She is currently engaged in her own plywood business, where she oversees general
management operations. With a decade of extensive experience in general management, Mrs. Mac
effectively supervises a diverse array of business functions, including strategic planning, team leadership,
and performance management. Consequently, she is anticipated to bring objective and independent
insights to corporate decisions, maintain high ethical standards, and prioritize the interests of all
stakeholders.

Further, in the opinion of the Board, all our Independent Directors possess requisite qualifications,
experience, expertise and hold high standards of integrity for the purpose of Rule 8(5)(iiia) of the
Companies (Accounts) Rules, 2014 as amended up to the date. List of key skills, expertise and core
competencies of the Board, including the Independent Directors, is provided in Corporate Governance
Report.

18. PARTICULARS OF LOANS, INVESTMENTS OR GUARANTEE BY COMPANY UNDER SECTION 186
OF THE COMPANIES ACT, 2013

Pursuant to Section 186 of the Companies Act, 2013 read with Schedule V of the SEBI Listing Regulations
disclosure on particulars relating to Investment are stated in Note No. 3 of Standalone Financial
Statement. Further your company has not given any loan or advances in nature of loan to any other Body
Corporate or person. During the financial year, no new investments made by the company in securities.
However, details of outstanding investments in securities given are disclosed as under: ......

Name of Company

Nature of
Transaction

Investment/Guarantee
/Loan provided

Closing
value as on
31.03.2025

Simran Hatcheries Private Limited
CIN: U01222MP1991PTC006818

Non -Current

Investment in Equity
Instruments
(Unquoted)

11.89

PUREGENE BIOTECH LIMITED
CIN: U01222MP1999PLC013303

Non -Current

Investment in Equity
Instruments
(Unquoted)

119.65

The above stated investment, loan and Guarantee are within the limits as specified under Section 186 of
the Companies Act, 2013.

19. PARTICULARS OF CONTRACT OR ARRANGEMENT WITH RELATED PARTIES

In line with the requirements of the Companies Act, 2013 and the SEBI Listing Regulations, the Company
has formulated a Policy on Related Party Transactions. The Policy can be accessed on the Company’s
website at the web-link:

http://www.simranfarms.com/pdf/policy/related_party_transaction_policy.pdf

The Policy intends to ensure that proper reporting; approval and disclosure processes are in place for all
transactions between the Company & Related Parties.

All Related Party Transactions are subjected to independent review by an Audit Committee to establish
compliance with the requirements of Related Party Transactions under the Companies Act, 2013 and
SEBI Listing Regulations. Prior omnibus approval is obtained for related party transactions which are of
repetitive nature and entered in the ordinary course of business and on an arm's length basis.

All Related Party Transactions entered during the year 2024-25 were in Ordinary Course of the Business
and at Arm's Length basis. Further the disclosure of Related Party Transactions as required under Section
134(3)(h) of the Companies Act, 2013 and Rule 8(2) Companies (Accounts) Rules, 2014 and the Material
Related Party Transactions, i.e. transaction(s) to be entered into individually or taken together with
previous transactions during a financial year, exceeds rupees one thousand crore or ten per cent of the
annual consolidated turnover of the listed entity as per the last audited financial statements of the listed
entity, whichever is lower; which were entered during the year by your company have been reported in
Form AOC-2 is set out as
ANNEXURE-B and form part of this report.

Details of related party transactions entered into by the Company, in terms of Ind AS-24 have been
disclosed in the notes to the Standalone/Consolidated financial statements forming part of this Report &
Annual Accounts 2024-25.

20. CONSERVATION OF ENERGY, TECHNOLOGY ABSORPTION, FOREIGN EXCHANGE EARNINGS
AND OUTGO

The particulars in respect of conservation of energy, technology absorption and foreign exchange
earnings and outgo, as required under sub-section (3)(m) of Section 134 of the Companies Act, 2013 read
with Rule (8)(3) of the Companies (Accounts) Rules, 2014 as amended up to the date are given as under:

(A) Conservation of Energy

(i) The steps taken or impact on conservation of energy: The operations of the Company do
not involve substantial consumption of energy in comparison to operational cost.
Nevertheless, the Company continues its efforts to conserve energy wherever practicable,
by economizing on the use of power at the farms, hatcheries and offices.

(ii) The steps taken by the company for utilizing alternate sources of energy: The Company
has used alternate source of energy, whenever and to the extent possible.

(iii) The capital investment on energy conservation equipment’s: Nil

(B) Technology Absorption

(i) The efforts made towards technology absorption: Not Applicable.

(ii) The benefits derived like product improvement, cost reduction, product development or
import substitution: Not Applicable.

(iii) In case of imported technology (imported during the last three years reckoned from the
beginning of the Financial Year): The Company has neither purchased within India nor
imported any technology.

(iv) The expenditure incurred on Research and Development: The Company has not incurred
any expenditure on Research and Development during the year under review.

(C) Foreign Exchange Earnings and Outgo

During the year under review, there was neither inflow nor outflow of foreign exchange.

21. STATEMENT IN RESPECT OF ADEQUACY OF INTERNAL FINANCIAL CONTROL WITH

REFERENCE TO THE FINANCIAL STATEMENTS

The Company has adequate Internal Controls Systems and the same are reviewed regularly. Beside there
are documented policies and procedures to support the system, so that all the applicable rules and
regulations are complied with; that all transactions are authorized, recorded and reported correctly and
adequately and that all the assets of the Company are safeguarded and there is no unauthorized use
thereof. The Audit Committee reviews reports presented by the internal auditors on a routine basis.
Further, the Audit Committee maintains constant dialogue with statutory and internal auditors to ensure
that internal control systems are operating effectively.

The Company’s internal control system is commensurate with its size, scale and complexities of its
operations. Such controls have been assessed during the year under review taking into consideration the
essential components of internal controls stated in the Guidance Note on Audit of Internal Financial
Controls Over Financial Reporting issued by The Institute of Chartered Accountants of India.

However, your Company recognizes that Internal Financial Controls cannot provide absolute assurance of
achieving financial, operational and compliance reporting objectives because of its inherent limitations.
Accordingly, regular audits and review processes ensure that such systems are reinforced on an ongoing
basis.

22. CORPORATE SOCIAL RESPONSIBILITY (CSR)

During the financial year 2024-25, your Company has not met criteria laid down under the provisions of
Section 135(1) of the Companies Act, 2013 read with companies (Corporate Social Responsibility Policy)
Rules, 2014 and accordingly the provisions Corporate Social Responsibility are not applicable to the
Company.

During the current financial year 2025-26, the Company has under taken to spend on its CSR activities
every year, 2% of its average Net Profits during every block of three years. ‘Net Profit’ shall be calculated in
the manner prescribed by the Act and the CSR Rules.

Pursuant to Section 135(9) where the amount to be spent by a Company under sub-section (5) does not
exceed Rupees Fifty Lakhs, the requirement under sub-section (1) for constitution of the Corporate Social
Responsibility Committee shall not be applicable and the functions of such Committee provided under this
section shall, in such cases, be discharged by the Board of Directors of such company. Since the proposed
amount of CSR expenditure is less than Rupees Fifty Lakhs, the Company is not required to constitute the
CSR Committee and the functions of CSR Committee shall be performed by the Board of Directors.

Further, expenses towards CSR activities will be done in current financial year and will be reviewed time to
time. The Company’s CSR Policy lays out the vision, objectives and implementation
mechanism. Copy of CSR policy is available at the website of the Company at
http://www.simranfarms.com/pdf/policy/corporate_social_responsibility.pdf.

The Company’s CSR activities have been traditionally focused on education, skill development, health,
environment and promoting sustainable practices which shall be part of the schedule VII of the Companies
Act, 2013.

23. NOMINATION AND REMUNERATION POLICY/DISCLOSURE RELATING TO REMUNERATION OF
DIRECTORS / KEY MANAGERIAL PERSONNEL AND PARTICULARS OF EMPLOYEES

In accordance with Section 178 and other applicable provisions if any, of the Companies Act, 2013 read
with the Rules issued there under and the SEBI Listing Regulations, the Board of Directors formulated the
Nomination and Remuneration Policy of your Company on the recommendations of the Nomination and
Remuneration Committee. Pursuant to Section 134(3) of the Companies Act, 2013, the Nomination and
Remuneration policy of the Company which laid down the criteria for determining qualifications,
competencies, positive attributes, independence for appointment of Directors and remuneration of
Directors, KMP and other employees.

Details on the Remuneration Policy are available on the Company’s website at web-link:
http://simranfarms.com/pdf/policy/nomination_renumeration.pdf

The Board of Directors affirms that the remuneration paid to directors, senior management and other
employees is in accordance with the remuneration policy of the Company.

The Disclosure required under Section 197(12) of the Companies Act, 2013 read with Rule 5 of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014 as amended up to
date, is annexed as
ANNEXURE-C and forms an integral part of the Board Report.

During the year under review, none of the employee of the Company is drawing remuneration more than
INR 1,02,00,000/- per annum or INR 8,50,000/- per month for the part of the year. Therefore, details of top
ten employees in terms of the receipt of remuneration as prescribed under rule 5(2) of the Companies
(Appointment and Remuneration of Managerial Personnel) Rules, 2014, as amended, containing details
prescribed under rule 5(3) of the said rules, will be made available to any member on request, as per
provisions of Section 136(1) of the Act. Any Member desirous of obtaining above said details may write to
the Company Secretary or email at compliance@simranfarms.com

Pursuant to Section 197(14) of the Companies Act, 2013, during the financial year, none of the directors of
the Company received any commission from the company nor received any remuneration or commission
from the subsidiary company. However No Director was disqualified for receiving any remuneration or
commission from the Company/Subsidiary Company during the period under review.

24. DISCLOSURE OF ESTABLISHMENT OF VIGIL MECHANISM/WHISTLE BLOWER POLICY

As per the requirement of Section 177(9) & (10) of the Companies Act, 2013 and Schedule V of SEBI
Listing Regulations, the Company has established a “Whistle Blower Policy” for directors and employees
to enable the directors, employees and all stakeholders of the Company to report genuine concerns about
unethical behavior, actual or suspected fraud, or violation of the Company’s code of conduct and ethics
and to provide for adequate safeguards against victimization of persons who use such mechanism and
make provision for direct access to the Chairperson of the Audit Committee. Further, no person has been
denied direct access to the Chairperson of the Audit Committee.

The details of the “Whistle Blower Policy” have been uploaded on the Company’s website and can be
accessed at the web link: http://simranfarms.com/pdf/policy/vigil_mechanism.pdf

25. SECRETARIAL AUDITORS AND SECRETARIAL AUDIT REPORT
Secretarial Auditors

In terms of Section 204 of the Companies Act, 2013 and Companies (Appointment and Remuneration of
Managerial Personnel) Rules, 2014 as amended from time to time, the Board had appointed Ramesh
Chandra Bagdi & Associates, Practicing Company Secretaries, Indore (Certificate of Practice Number:
2871) to undertake the Secretarial Audit of the Company for the Financial Year 2024-25.

Further pursuant to the amended provisions of Regulation 24A of the SEBI (Listing Obligations and
Disclosure Requirements) Regulations, 2015 and Section 204 of the Act read with Rule 9 of the
Companies (Appointment and Remuneration of Managerial Personnel) Rules, 2014, on the
recommendation of the Audit Committee, the Board of Directors in their meeting held on 13th August, 2025
appointed Ramesh Chandra Bagdi & Associates, Practicing Company Secretaries (PCS Registration No.
2871) as the Secretarial Auditors of your Company subject to approval of members in ensuing 38th Annual
General Meeting (“AGM”) for the period of five consecutive financial year starting from 2025-26 to 2029-
2030 at such remuneration as shall be fixed by the Board/Committee. Your Company has received their
written consent that the appointment is in accordance with the applicable provisions of the Act and rules
framed thereunder. The Secretarial Auditors have confirmed that they are not disqualified to be appointed
as the Secretarial Auditors of your Company for the audit of five consecutive financial year i.e. from 2025¬
26 to 2029-30.

Secretarial Audit Report

The Secretarial Audit Report given by the Secretarial Auditor of the Company is annexed as
ANNEXURE-D and forms an integral part of this Report, which is self-explanatory.

Further, the Secretarial Audit Report does not contain any qualifications, reservations or adverse remarks
or disclaimer report except the following with Board’s explanation:

Secretarial Auditor Observations

Management comments

Pursuant to the provisions of Regulation 3(5) of
Securities and Exchange Board of India (Prohibition
of Insider Trading) (Amendment) Regulations, 2018
Company has not maintained the database of
sharing UPSI of financials of subsidiary company at
the time of finalization of quarterly/ annual results.

Inadvertently details of sharing UPSI of financials of
subsidiary company at the time of finalization of
quarterly/annual results were not updated. Noted
for future course of action.

26. ANNUAL SECRETARIAL COMPLIANCE REPORT

The Company had appointed Ramesh Chandra Bagdi & Associates Practicing Company Secretaries to
undertake an audit for the financial year 2024-25 for all applicable compliances as per SEBI Regulations
and Circulars/Guidelines issued there under. Pursuant to provision of Regulation 24A of SEBI Listing
Regulations, the Annual Secretarial Compliance Report for the financial year 2024-25 has been submitted
to the stock exchange within prescribed time.

27. STATUTORY AUDITORS

Khandelwal Kakani & Company, Chartered Accountants, Indore (ICAI Firm Registration No. 001311C)
were appointed as the Statutory Auditors of your company in the 35th Annual General Meeting (AGM) of
the Company held on 15th September, 2022 for term of 5 consecutive years, from the conclusion of 35th
Annual General Meeting up to the conclusion of 40th Annual General Meeting to be held in the calendar
year 2027.

EXPLANATION TO AUDITOR’S REMARKS

The Auditors in their report have referred to the notes forming part of the accounts which are self¬
explanatory and does not contain any qualification, reservation or adverse remark or disclaimer and do not
call for any further explanation/clarification by the Board of Directors.

During the year under review, the Statutory Auditors have not reported any instances of frauds committed
in the Company by its Officers or Employees to the Audit Committee under Section 143(12) of the
Companies Act, 2013.

28. INTERNALAUDITOR

The Company has appointed CS Tanu Parmar as Internal Auditor of the Company and takes her
suggestions and recommendations to improve and strengthen the internal control systems. Her scope of
work includes review of operational efficiency, effectiveness of systems & processes, compliances and
assessing the internal control strengths in all areas.

The Audit Committee reviews adequacy and effectiveness of the Company’s internal control environment

and monitors the implementation of audit recommendations including those relating to strengthening of
the Company’s risk management policies and systems.

29. COSTAUDIT

Your Company does not fall within the provisions of Section 148 of Companies Act, 2013 read with the
Companies (Cost Records & Audit) Rules, 2014 as amended from time to time, therefore no such records
are required to be maintained.

30. REPORT ON CORPORATE GOVERNANCE AND MANAGEMENT DISCUSSION AND ANALYSIS

Your Company has complied with the Corporate Governance requirements under Companies Act, 2013
and as stipulated under the provisions of the SEBI Listing Regulations. A detailed Report on Corporate
Governance forms part of this Annual Report. A detailed analysis of the Company’s performance is
discussed in the Management Discussion and Analysis Report, which forms part of this Annual Report.

31. MD & CFO CERTIFICATION

The Managing Director & CFO of your Company have issued necessary certificate pursuant to the
provisions of Regulation 17(8) of the SEBI Listing Regulations and the same forms part of this Annual
Report.

32. CODE OF CONDUCT

The Board has laid down a Code of Conduct (‘the Code”) for all Board Members and Senior Management
and Independent Directors of the Company. All the Board Members including Independent Directors and
Senior Management Personnel have affirmed compliance with the Code of Conduct. Declaration on
adherence with the Code of Conduct is forming part of the Corporate Governance Report.

The policy on Code of Conduct has been uploaded on the Company’s website at the web link:
http://simranfarms.com/pdf/policy/code_of_conduct.pdf

33. STATEMENT INDICATING DEVELOPMENT & IMPLEMENTATION OF RISK MANAGEMENT

Your Company has a well-defined risk management framework in place. The risk management framework
works at various levels across the organization. The Board of Directors have developed & implemented
Risk Management Policy for the Company which provides for identification, assessment and control of
risks which in the opinion of the Board may threaten the existence of the Company. The Management
identifies and controls risks through a properly defined framework in terms of the aforesaid policy.

34. MATERIAL CHANGES & COMMITMENTS, IF ANY, AFFECTING THE FINANCIAL POSITION OF THE
COMPANY

No material changes and commitments, affecting the financial position of the Company, have occurred
between the end of the financial year to which the financial statements relate and the date of this Board’s
Report.

35. ENVIRONMENT AND SAFETY

The Company is conscious of the importance of environmentally clean and safe operations. The
Company’s policy required conduct of operations in such a manner, so as to ensure safety of all
concerned, compliances environmental regulations and preservation of natural resources.

36. DISCLOSURE UNDER THE SEXUAL HARASSMENT OF WOMEN AT WORKPLACE (PREVENTION,
PROHIBITION AND REDRESSAL) ACT, 2013

The Company has in place an Anti-Sexual Harassment Policy in line with the requirements of Sexual

Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013. An Internal
Complaints Committee (ICC) has been set up to redress the Complaint received regarding sexual
harassment.

The Company has complied with provisions relating to the constitution of Internal Complaints Committee
under The Sexual Harassment of Women at Workplace (Prevention, Prohibition and Redressal) Act, 2013.
All employees (permanent, contractual, temporary, trainees) are covered under this Policy. The status of
the complaints filed, disposed and pending during the financial year 2024-25 is given below:-

S. No

Particulars

No. of Complaints

a

Number of Complaints of Sexual Harassment received in the year

Nil

b

Number of Complaints disposed during the year

Nil

c

Number of cases pending for more than ninety days

Nil

37. LISTING WITH STOCK EXCHANGES

The Company’s shares are listed on BSE Limited. The Company has paid Annual Listing Fee for Financial
Year 2025-26.

38. INSURANCE

The Company’s assets are adequately insured against the loss of fire and other risk, as considered
necessary by the Management from time to time.

39. COMPLIANCE OF SECRETARIAL STANDARD

Your Company is in compliance with the applicable Secretarial Standards, issued by the Institute of
Company Secretaries of India and approved by the Central Government under Section 118(10) of the
Companies Act, 2013.

40. DEPOSITORY SYSTEM

Your Company’s shares are tradable compulsorily in electronic form and your Company has connectivity
with both the Depositories i.e. National Securities Depository Limited (NSDL) and Central Depository
Services (India) Limited (CDSL). In view of the numerous advantages offered by the Depository System,
members are requested to avail the facility of Dematerialization of the Company’s shares on either of the
Depositories mentioned as aforesaid. The Company has paid the Annual Custody Fee to both the
depositories for Financial Year 2025-26.

41. INDUSTRIAL RELATIONS

Company’s Industrial relations continued to be healthy, cordial and harmonious during the period under
review. Your directors record their appreciation for all the efforts, support and co-operation of all
employees extended from time to time.

42. DESIGNATED PERSON FOR THE PURPOSE OF DECLARATION OF BENEFICIAL INTEREST IN THE
SHARES OF THE COMPANY:

Pursuant to provision of Rule 9(4) of Companies (Management and Administration) Rules, 2014 as
amended by MCA vide Notification dated 27th October, 2023, every Company required to designate a
person who shall be responsible for furnishing, and extending cooperation for providing, information to the
Registrar or any other authorized officer with respect to beneficial interest in shares of the company.

Accordingly, the Company has appointed CS Tanu Parmar (ACS: 34769), Company Secretary of the

Company, as Designated Person for the purpose of declaration of beneficial interest in the shares of the
Company

43. OTHER DISCLOSURES:

Your directors state that no disclosure or reporting is required in respect of the following items as there
were no transactions/events on these items during the year under review: -

0 No Significant or material orders passed by the Regulators or Courts or Tribunals which impact the
going concern status and the Company’s operation in future.

0 Voting rights which are not directly exercised by the employees in respect of shares for the
subscription/ purchase of which loan was given by the Company (as there is no scheme pursuant
to which such persons can beneficially hold shares as envisaged under section 67(3)(c) of the
Companies Act, 2013).

0 There has been no change in the nature of business of your Company.

0 The Business Responsibility Reporting as required by Regulation 34(2) of the SEBI Listing

Regulations, is not applicable to your Company for the financial year ending March 31,2025.

0 No application was made or any proceeding is pending under the Insolvency and Bankruptcy
Code, 2016 during the year in respect of your Company.

0 There was no one time settlement of loan obtained from the Banks or Financial Institutions.

0 There was no revision of financial statements and Board's Report of the Company during the year

under review.

0 The Company has complied with the provisions of Maternity Benefit Act, 1961 during the year
under review.

44. ACKNOWLEDGEMENTS

The Board of Directors of your company wish to express their deep gratitude towards the valuable co¬
operation and support received from the various Ministries and Departments of Government of India,
various State Governments, the Banks/Financial Institutions and other stakeholders such as
shareholders, customers and suppliers, vendors etc. Further, the Board places its special appreciation for
the co-operation and continued support extended by employees of the Company at all levels whose
enthusiasm drives the Company to grow and excel.

For and on behalf of the Board of Directors of
SIMRAN FARMS LIMITED

Harender Singh Bhatia Kawaljeet Singh Bhatia

Date : 13th August, 2025 Managing Director Director

Place: Indore DIN: 00509426 DIN: 00401827

Prevent Unauthorized Transactions in your demat account -> Update your Mobile Number with your Depository Participant. Receive alerts on your Registered Mobile for all debit and other important transactions in your demat account directly from NSDL on the same day....................issued in the interest of investors.
KYC is one-time exercise while dealing in securities markets -> Once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.